当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2013年第1期
编号:12361781
阿卡波糖过敏1例(2)
http://www.100md.com 2013年1月5日 《中国医药导报》 2013年第1期
     [参考文献]

    [1] 陈新文,韩加情.阿卡波糖的临床应用及不良反应[J].药物流行病学杂志,2005,14(2):70.

    [2] Wehmeier UF,Piepersberg W. Biotechnology and molecular biology of the α-glucosidase inhibitor acarbose [J]. Appl Microbiol Biotechnol,2004,63:613-625.

    [3] Lee S,Saueribrei B,Niggemann J,et al. Biosynthesic studies on the α-glucosidase inhibitor acarbose in Actinoplanes sp:source of the maltose unit [J]. J Antibiot,1997,50:954-961.

    [4] Stratmann A,Mahmud T,Lee S,et al. The AcbC protein from Actinoplanes specise is a C7-cyclitol synthase related to 3-dehydroquinate synthases and is involved in the biosynthesis of the α-glucosidase inhibitor acarbose [J]. The Journal of Biological Chemistry,1999,274(16):10889-10896.

    [5] Heine RJ,Balkau B,Ceriello A,et al. What dose postprandial hyperglycaemia mean? [J]. Diabet Med,2004,21(2):208.

    [6] Hanefeld M,Haffner SM,Menschikowski M,et al. Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes [J]. Diabetes Res Clin Pract,2002,55(2):221.

    (收稿日期:2012-08-27 本文编辑:郝明明), http://www.100md.com(罗晶)
上一页1 2